Ricardo F. Allegri

Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study

Maulikkumar Patel, Wei Feng, Nicole Sarah McKay, Nicole S Mckay et autres

BACKGROUND: Individuals with autosomal dominant Alzheimer's disease (ADAD) arising from mutations in PSEN1, PSEN2, or APP exhibit variability in clinical presentation. Genetic studies of ADAD have shaped our understanding of the disease, and the discovery of genetic modifiers can inform therapeutic interventions …

us, gb (code pays fourni par la source)

Consenso Argentino para el diagnóstico de Diagnóstico de las demencias. Primera parte: introducción, metodología de trabajo, escenario actual y algoritmos diagnósticos

Pablo Bagnati, Ricardo F. Allegri, Ignacio Demey, Gastón Bartoli et autres

The Argentine Consensus on the Diagnosis of Dementia is an initiative of the Argentine Association of Biological Psychiatry (AAPB). The primary aim of this document was to develop an efficient tool for the early diagnosis of dementia, targeting both primary care physicians …

ar, br, us, cu, co (code pays fourni par la source)

Plasma levels of an N‐terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's disease

Stephanie A. Schultz, Yi Rao, L Liu, Beth L. Ostaszewski et autres

INTRODUCTION: Tau species lacking truncation of the N-terminal region, including plasma N-terminal tau fragment 1 (NT1), have been previously associated with cognitive decline, neurodegeneration, and tau pathology in late-onset sporadic Alzheimer's disease (AD). METHODS: Here, we examined cross-sectional and longitudinal plasma NT1 …

us, ar, gb, de, jp, au (code pays fourni par la source)

Reaction to Health Emergencies

Ismael L. Calandri, Ricardo F. Allegri

ar (code pays fourni par la source)